Results 151 to 160 of about 108,615 (251)

Infectious Mononucleosis: An Uncommon Presentation of a Common Disease—a Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
Atypical infectious mononucleosis without pharyngitis may mimic malignancy; early EBV testing enables accurate diagnosis and prevents unnecessary invasive investigations. ABSTRACT Infectious mononucleosis (IM), caused by the Epstein–Barr virus (EBV), typically presents with fever, pharyngitis, and lymphadenopathy.
Mohammad Moini, Shiva Sheibani, Matin Ghazizadeh   +2 more
wiley   +1 more source

Case Report: A pediatric case of chronic active Epstein-Barr virus infection complicated by pulmonary arterial hypertension. [PDF]

Front Cardiovasc Med
Zhang M, Wang K, Xu X, Ji W, Liu T, Gao W, Guo Y.   +6 more
europepmc   +1 more source

A Rare Case of Pediatric Gastric Inflammatory Myofibroblastic Tumor (IMT) Mimicking Gastrointestinal Stromal Tumor (GIST): A Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Gastric inflammatory myofibroblastic tumor is a rare entity in children that may present with nonspecific gastrointestinal symptoms. Complete surgical excision remains both diagnostic and curative, with favorable postoperative outcomes and low recurrence risk when adequately resected.
Rajabu Athumani Bakari, Alfred Chibwae, Amour Ally Mwinyi, Alex Mashaka, Catherine Mtui, Aidah Kenseko, Boniface Kahindi Kazungu, William Malinda Lutege, Godfrey Masalu Mchele   +8 more
wiley   +1 more source

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report. [PDF]

Front Med (Lausanne)
Kanesada K, Yoshimatsu K, Yano S, Higashida M, Okada T, Endo S, Fujiwara Y, Ueno T.   +7 more
europepmc   +1 more source

Recurrent Cytopathic Effects and Prolonged Viral Shedding in an Immunocompromised Patient With Malignant Lymphoma Treated With Rituximab and Bendamustine: A Case of Coronavirus Disease 2019 Relapse

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT A 79‐year‐old woman with malignant lymphoma initially recovered from mild coronavirus disease 2019 (COVID‐19), but later developed pneumonia. Despite continuous PCR positivity, cytopathic effect (CPE) temporarily became negative before re‐emerging with clinical deterioration.
Takahisa Ohira, Taku Ogawa, Tomoko Tanaka, Shoichi Sakaguchi, Youichi Suzuki, Hong Wu, Tomoyuki Yamada, Yuriko Shibata, Kazuki Iwaki, Ayana Okazaki, Akira Ukimura, Takashi Nakano   +11 more
wiley   +1 more source

Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
McCutcheon KM, Bodansky A, Ngo TT, Caspar C, Quintana S, Asaki J, Zhou J, Caillier SJ, Sharathchandra A, Waldrop G, Dandekar R, Zorn K, Tubati A, Gupta S, Sabatino JJ, Cuneo R, Oksenberg J, Wallin MT, Cree BAC, Hauser SL, Pleasure S, Derisi J, Wilson MR, and the UCSF ORIGINS/EPIC team.   +23 more
europepmc   +1 more source

Successful Management of Suspected Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in BRAF‐Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report

Cancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background The BRAF V600E mutation is a rare genetic alteration in cholangiocarcinoma for which sequential therapy with immune checkpoint inhibitors (ICIs) and BRAF/MEK inhibitors may be effective. However, the full spectrum of adverse events associated with the sequential use of these agents remains unclear. Hemophagocytic lymphohistiocytosis
Akira Shibata, Michihiro Ono, Shutaro Oiwa, Atsushi Uesugi, Seiya Saito, Makoto Usami, Tomoyuki Abe, Masahiro Yoshida, Masahiro Maeda, Kohichi Takada   +9 more
wiley   +1 more source

Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders. [PDF]

Can Liver J
Coman D, Hercun J, Corsilli D, Chapdelaine H, Cros G, Bilodeau M.   +5 more
europepmc   +1 more source

An Optimized Protocol for the Generation of iPSC Lines from Lymphoblastoid Cell Lines Using the Non‐integrative Sendai Virus

Current Protocols, Volume 6, Issue 3, March 2026.
Abstract The choice of cell source for generating induced pluripotent stem cells (iPSCs) is influenced by several factors, including accessibility, reprogramming efficiency, and the invasiveness of the cell collection procedure. Traditional sources such as skin fibroblasts or peripheral blood mononuclear cells often require invasive sampling, which can
Laurie Martineau, Isabella Bienjonetti, Sabrina Bellenfant, Jack Puymirat, François Gros‐Louis   +4 more
wiley   +1 more source

Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future. [PDF]

Neurol Neuroimmunol Neuroinflamm
Wahbeh F, Sabatino JJ.
europepmc   +1 more source